medRxiv·24 SepVarenicline as a Repurposable Drug Candidate for ADRD PreventionPreprint: cohort study of 9,584 peoplePopulationsPaper
Translational Psychiatry·16 SepRegional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer's diseaseStudy in peopleMechanismsPaper
GSA 2025 Abstract·3 JanHybrid Value-Aware Transformer Identifies Novel and Suspected Drugs for Alzheimer’s DiseaseStudy in peopleAI & dataPaper
GSA 2025 Abstract·3 JanRisk Factors and Management Strategies for Cerebral Amyloid AngiopathyReviewPopulationsPaper
AAIC 2025 Abstract·26 DecAssociation of Different Statins with Incident ADRD: A Target Trial Emulation StudyStudy in peopleInterventionsPaper
AAIC 2025 Abstract·26 DecNon‐inferior screen fail rate for persons under the age of 65 in an anti‐amyloid monoclonal antibody clinical trial on Alzheimer’s DiseaseTrial in peoplePopulationsPaper
AAIC 2025 Abstract·26 DecA pilot medication‐wide association study for ADRD drug repurposing using the Million Veteran ProgramStudy in peoplePopulationsPaper
GSA 2024 Abstract·1 JanTHE ASSOCIATIONS OF LATE-LIFE BLOOD PRESSURE WITH CERAD AND BRAAK STAGES: FINDINGS FROM THE NACC DATASETStudy in peoplePopulationsPaper